Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

776 Results

Document

OBSP-Screening-Report-Template-without-breast-implants.pdf

Jun 2024

Document

ONE-ID-CPSO-Registration-Guide-for-New-Users-EN.pdf

Jul 2024

Document

ONE-ID-CPSO-Registration-Guide-for-New-Users-FR.pdf

Jul 2024

Document

ONE-ID-Identity-Access-Management-Service-EN.pdf

Jul 2024

Document

ONE-ID-Identity-Access-Management-Service-FR

Jul 2024

Regimen

NIVL+RELA

Cancer Type:

Skin,

Melanoma

Show More Show more tags

, Show Less Show fewer tags

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab and Relatlimab - Advanced Melanoma (Unresectable or Metastatic Melanoma)

Show More Show more tags

, Show Less Show fewer tags

Drugs Used:

nivolumab / relatlimab

... Show more tags

, Collapse Show fewer tags

Quick Link(s):

Regimen Monograph

Nov 2024

Document

obsp-7-22-24.xml

Jul 2024

Document

obsp-7-22-24.html

Jul 2024

Document

OntarioCancerProfilesProjectionsAppendix.xlsx

Aug 2024

Document

OBSP-Digital-Breast-Tomosynthesis-Report-Template-with-breast-implants.pdf

Sep 2024

Document

OBSP-Digital-Breast-Tomosynthesis-Report-Template-without-breast-implants.pdf

Sep 2024

Document

no-harm.png

Sep 2024

Pages